PARMAR KUSH
Insider CIK 1664281 · IMPL 10% owner · SKYE 10% owner · SCPH Director · BOLD Director · ARVN Director · FIXX Director, 10% owner · ELVN 10% owner · TRDA Director, 10% owner · AKUS Director, 10% owner · CAMP 10% owner · RLYB Director, 10% owner · CABA 10% owner · APRE 10% owner · VOR Director, 10% owner · ARTV 10% owner · FVAM Co-CEO, Director, 10% owner · CINC 10% owner · LTGO 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SKYE Skye Bioscience, Inc. | S Sale | 2026-09-23 | 2026-09-24 | 114,851 | $1.61 | $184.9K | 0 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2026-09-23 | 2026-09-24 | 4,528 | $1.61 | $7.3K | 0 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2026-09-23 | 2026-09-24 | 4,528 | $1.61 | $7.3K | 0 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2026-09-23 | 2026-09-24 | 114,851 | $1.61 | $184.9K | 0 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2026-09-22 | 2026-09-24 | 27,612 | $1.65 | $45.6K | 114,851 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2026-09-22 | 2026-09-24 | 1,088 | $1.65 | $1.8K | 4,528 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2026-09-22 | 2026-09-24 | 1,088 | $1.65 | $1.8K | 4,528 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2026-09-22 | 2026-09-24 | 27,612 | $1.65 | $45.6K | 114,851 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2026-09-16 | 2026-09-18 | 32,607 | $1.91 | $62.3K | 142,463 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2026-09-16 | 2026-09-18 | 1,285 | $1.91 | $2.5K | 5,616 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2026-09-16 | 2026-09-18 | 1,285 | $1.91 | $2.5K | 5,616 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2026-09-16 | 2026-09-18 | 32,607 | $1.91 | $62.3K | 142,463 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2026-08-20 | 2026-08-20 | 1,159 | $0.32 | $371 | 1,400,560 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2026-08-20 | 2026-08-20 | 6,495 | $0.32 | $2.1K | 7,850,155 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2026-08-20 | 2026-08-20 | 46 | $0.32 | $15 | 55,208 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2026-08-20 | 2026-08-20 | 6,495 | $0.32 | $2.1K | 7,850,155 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2026-08-20 | 2026-08-20 | 46 | $0.32 | $15 | 55,208 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2026-08-20 | 2026-08-20 | 1,159 | $0.32 | $371 | 1,400,560 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2026-08-19 | 2026-08-20 | 409 | $0.35 | $143 | 55,254 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2026-08-19 | 2026-08-20 | 57,476 | $0.35 | $20.1K | 7,856,650 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2026-08-19 | 2026-08-20 | 10,255 | $0.35 | $3.6K | 1,401,719 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2026-08-19 | 2026-08-20 | 57,476 | $0.35 | $20.1K | 7,856,650 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2026-08-19 | 2026-08-20 | 409 | $0.35 | $143 | 55,254 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2026-08-19 | 2026-08-20 | 10,255 | $0.35 | $3.6K | 1,401,719 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2026-08-18 | 2026-08-20 | 253,080 | $0.38 | $96.2K | 7,914,126 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2026-08-18 | 2026-08-20 | 1,830 | $0.38 | $695 | 55,663 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2026-08-18 | 2026-08-20 | 45,090 | $0.38 | $17.1K | 1,411,974 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2026-08-18 | 2026-08-20 | 253,080 | $0.38 | $96.2K | 7,914,126 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2026-08-18 | 2026-08-20 | 1,830 | $0.38 | $695 | 55,663 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2026-08-18 | 2026-08-20 | 45,090 | $0.38 | $17.1K | 1,411,974 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-12 | 3,152,305 | — | $0 | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-12 | 1,823,238 | — | $0 | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-12 | 866,018 | — | $0 | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-12 | 1,484,401 | — | $0 | 0 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-08-10 | 2026-08-10 | 92,444 | $7.00 | $647.1K | 2,691,337 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion | 2026-08-10 | 2026-08-12 | 4,975,543 | — | $0 | 4,975,543 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion | 2026-08-10 | 2026-08-12 | 2,350,419 | — | $0 | 2,350,419 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-08-10 | 2026-08-10 | 92,444 | $7.00 | $647.1K | 2,691,337 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-12 | 1,484,401 | — | $0 | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-12 | 866,018 | — | $0 | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-12 | 1,823,238 | — | $0 | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-12 | 3,152,305 | — | $0 | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion | 2026-08-10 | 2026-08-12 | 2,350,419 | — | — | 2,350,419 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion | 2026-08-10 | 2026-08-12 | 4,975,543 | — | — | 4,975,543 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-08-07 | 2026-08-10 | 52,317 | $6.85 | $358.4K | 2,783,781 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-08-07 | 2026-08-10 | 52,317 | $6.85 | $358.4K | 2,783,781 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-08-06 | 2026-08-10 | 10,494 | $7.00 | $73.5K | 2,836,098 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-08-06 | 2026-08-10 | 10,494 | $7.00 | $73.5K | 2,836,098 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | P Buy deriv | 2026-08-03 | 2026-08-05 | 3,179,558 | $1.53 | $4.86M | 3,179,558 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | P Buy deriv | 2026-08-03 | 2026-08-05 | 3,179,558 | $1.53 | $4.86M | 3,179,558 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-07-31 | 2026-08-03 | 1,718 | $6.85 | $11.8K | 2,846,592 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-07-31 | 2026-08-03 | 1,718 | $6.85 | $11.8K | 2,846,592 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-07-30 | 2026-08-03 | 114,756 | $6.93 | $795.3K | 2,848,310 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-07-30 | 2026-08-03 | 114,756 | $6.93 | $795.3K | 2,848,310 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | A Award deriv | 2026-06-10 | 2026-06-12 | 19,000 | — | $0 | 19,000 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2025-11-14 | 2025-11-18 | 200,000 | $8.80 | $1.76M | 2,963,066 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | P Buy | 2025-09-11 | 2025-09-15 | 2,941,176 | $1.53 | $4.50M | 2,941,176 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2025-08-22 | 2025-08-22 | 163,979 | $3.42 | $560.8K | 1,457,064 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2025-08-22 | 2025-08-22 | 6,470 | $3.42 | $22.1K | 57,493 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2025-08-21 | 2025-08-22 | 2,314 | $3.57 | $8.3K | 63,963 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2025-08-21 | 2025-08-22 | 58,642 | $3.57 | $209.4K | 1,621,043 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2025-07-09 | 2025-07-11 | 6,935 | $7.50 | $52.0K | 1,093,313 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2025-07-09 | 2025-07-11 | 20,065 | $7.50 | $150.5K | 3,163,066 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2025-07-01 | 2025-07-01 | 18,578 | $7.12 | $132.3K | 3,183,131 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2025-07-01 | 2025-07-01 | 6,422 | $7.12 | $45.7K | 1,100,248 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2025-06-30 | 2025-07-01 | 18,578 | $6.81 | $126.5K | 3,201,709 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2025-06-30 | 2025-07-01 | 6,422 | $6.81 | $43.7K | 1,106,670 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2025-06-27 | 2025-07-01 | 55,735 | $6.91 | $385.1K | 3,220,287 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2025-06-27 | 2025-07-01 | 19,265 | $6.91 | $133.1K | 1,113,092 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | A Award deriv | 2025-06-11 | 2025-06-12 | 19,000 | — | $0 | 19,000 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | C Conversion deriv | 2024-10-15 | 2024-10-15 | 4,244,770 | — | $0 | 0 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | C Conversion deriv | 2024-10-15 | 2024-10-15 | 3,395,816 | — | $0 | 0 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | C Conversion deriv | 2024-10-15 | 2024-10-15 | 15,002,166 | — | $0 | 0 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | P Buy | 2024-10-15 | 2024-10-15 | 909,090 | $11.00 | $10.00M | 2,625,145 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | C Conversion | 2024-10-15 | 2024-10-15 | 302,770 | — | $0 | 302,770 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | C Conversion | 2024-10-15 | 2024-10-15 | 1,716,055 | — | $0 | 1,716,055 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2024-09-13 | 2024-09-13 | 79 | $6.06 | $479 | 66,277 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2024-09-13 | 2024-09-13 | 2,000 | $6.06 | $12.1K | 1,679,685 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2024-09-13 | 2024-09-13 | 11,758 | $6.06 | $71.3K | 8,167,206 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2024-09-11 | 2024-09-13 | 36,504 | $6.60 | $240.9K | 1,681,685 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2024-09-11 | 2024-09-13 | 214,556 | $6.60 | $1.42M | 8,178,964 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2024-09-11 | 2024-09-13 | 1,440 | $6.60 | $9.5K | 66,356 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | C Conversion deriv | 2024-07-22 | 2024-07-24 | 843,592 | — | $0 | 0 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | C Conversion deriv | 2024-07-22 | 2024-07-24 | 214,692 | — | $0 | 0 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2024-07-22 | 2024-07-24 | 833,333 | $12.00 | $10.00M | 1,182,054 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | C Conversion | 2024-07-22 | 2024-07-24 | 1,058,284 | — | $0 | 1,058,284 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | J Other | 2024-07-22 | 2024-07-24 | 112,966 | $10.20 | $1.15M | 1,171,250 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | J Other | 2024-07-22 | 2024-07-24 | 348,721 | $10.20 | $3.56M | 348,721 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | A Award deriv | 2024-06-13 | 2024-06-14 | 16,000 | — | $0 | 16,000 | SEC↗ |
| RLYB Rallybio Corp | A Award deriv | 2024-05-15 | 2024-05-17 | 16,500 | — | $0 | 16,500 | SEC↗ |
| SKYE Skye Bioscience, Inc. | P Buy | 2024-03-13 | 2024-03-15 | 450,000 | $10.00 | $4.50M | 8,393,520 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-02-14 | 2024-02-16 | 688,358 | $14.90 | $10.26M | 3,200,634 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-02-14 | 2024-02-16 | 136,642 | $14.90 | $2.04M | 635,341 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-01-31 | 2024-02-02 | 82,813 | $15.00 | $1.24M | 771,983 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-01-31 | 2024-02-02 | 417,187 | $15.00 | $6.26M | 3,888,992 | SEC↗ |
| SKYE Skye Bioscience, Inc. | P Buy | 2024-01-31 | 2024-02-02 | 5,206,074 | $2.31 | $12.03M | 7,943,520 | SEC↗ |
| RLYB Rallybio Corp | A Award deriv | 2024-01-02 | 2024-01-04 | 27,118 | $1.77 | $48.0K | 27,118 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2023-09-26 | 2023-09-28 | 32,711 | $15.00 | $490.7K | 854,796 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2023-09-26 | 2023-09-28 | 164,789 | $15.00 | $2.47M | 4,306,179 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2023-08-24 | 2023-08-28 | 367,124 | $16.00 | $5.87M | 4,470,968 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2023-08-24 | 2023-08-28 | 72,876 | $16.00 | $1.17M | 887,507 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | A Award deriv | 2023-06-08 | 2023-06-12 | 16,000 | — | $0 | 16,000 | SEC↗ |
| RLYB Rallybio Corp | A Award deriv | 2023-05-17 | 2023-05-19 | 15,490 | — | $0 | 15,490 | SEC↗ |
| RLYB Rallybio Corp | S Sale | 2023-03-07 | 2023-03-09 | 100,000 | $8.20 | $820.0K | 2,378,969 | SEC↗ |
| CINC CinCor Pharma, Inc. | U Tender | 2023-02-24 | 2023-02-28 | 496,323 | — | $0 | 0 | SEC↗ |
| CINC CinCor Pharma, Inc. | U Tender | 2023-02-24 | 2023-02-28 | 3,953,990 | — | $0 | 0 | SEC↗ |
| CINC CinCor Pharma, Inc. | U Tender | 2023-02-24 | 2023-02-28 | 487,333 | — | $0 | 0 | SEC↗ |
| RLYB Rallybio Corp | A Award deriv | 2023-01-03 | 2023-01-05 | 10,344 | — | $0 | 10,344 | SEC↗ |
| AKUS Akouos, Inc. | D To issuer deriv | 2022-12-01 | 2022-12-02 | 16,000 | — | $0 | 0 | SEC↗ |
| AKUS Akouos, Inc. | U Tender | 2022-11-30 | 2022-12-02 | 3,153,333 | — | $0 | 0 | SEC↗ |
| AKUS Akouos, Inc. | U Tender | 2022-11-30 | 2022-12-02 | 982,453 | — | $0 | 0 | SEC↗ |
| CINC CinCor Pharma, Inc. | P Buy | 2022-08-15 | 2022-08-17 | 112,667 | $30.00 | $3.38M | 3,953,990 | SEC↗ |
| CINC CinCor Pharma, Inc. | P Buy | 2022-08-15 | 2022-08-17 | 487,333 | $30.00 | $14.62M | 487,333 | SEC↗ |
| AKUS Akouos, Inc. | A Award deriv | 2022-06-23 | 2022-06-27 | 16,000 | — | $0 | 16,000 | SEC↗ |
| FIXX Homology Medicines, Inc. | A Award deriv | 2022-06-15 | 2022-06-17 | 18,000 | — | $0 | 18,000 | SEC↗ |
| VOR Vor Biopharma Inc. | A Award deriv | 2022-06-14 | 2022-06-16 | 16,911 | — | $0 | 16,911 | SEC↗ |
| RLYB Rallybio Corp | S Sale | 2022-06-03 | 2022-06-07 | 50,329 | $12.50 | $629.1K | 1,251,755 | SEC↗ |
| RLYB Rallybio Corp | S Sale | 2022-06-03 | 2022-06-07 | 99,671 | $12.50 | $1.25M | 2,478,969 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | A Award deriv | 2022-06-02 | 2022-06-06 | 11,918 | — | $0 | 11,918 | SEC↗ |
| RLYB Rallybio Corp | A Award deriv | 2022-05-24 | 2022-05-26 | 13,440 | — | $0 | 13,440 | SEC↗ |
| RLYB Rallybio Corp | S Sale | 2022-05-23 | 2022-05-25 | 33,553 | $13.00 | $436.2K | 1,302,084 | SEC↗ |
| RLYB Rallybio Corp | S Sale | 2022-05-23 | 2022-05-25 | 66,447 | $13.00 | $863.8K | 2,578,640 | SEC↗ |
| RLYB Rallybio Corp | S Sale | 2022-02-08 | 2022-02-10 | 70,461 | $13.05 | $919.5K | 1,335,637 | SEC↗ |
| RLYB Rallybio Corp | S Sale | 2022-02-08 | 2022-02-10 | 139,539 | $13.05 | $1.82M | 2,645,087 | SEC↗ |
| CINC CinCor Pharma, Inc. | C Conversion deriv | 2022-01-11 | 2022-01-13 | 625,000 | — | $0 | 0 | SEC↗ |
| CINC CinCor Pharma, Inc. | C Conversion deriv | 2022-01-11 | 2022-01-13 | 2,525,000 | — | $0 | 0 | SEC↗ |
| CINC CinCor Pharma, Inc. | C Conversion deriv | 2022-01-11 | 2022-01-13 | 9,999,999 | — | $0 | 0 | SEC↗ |
| CINC CinCor Pharma, Inc. | P Buy | 2022-01-11 | 2022-01-13 | 312,500 | $16.00 | $5.00M | 496,323 | SEC↗ |
| CINC CinCor Pharma, Inc. | P Buy | 2022-01-11 | 2022-01-13 | 157,500 | $16.00 | $2.52M | 3,841,323 | SEC↗ |
| CINC CinCor Pharma, Inc. | C Conversion | 2022-01-11 | 2022-01-13 | 183,823 | — | $0 | 183,823 | SEC↗ |
| CINC CinCor Pharma, Inc. | C Conversion | 2022-01-11 | 2022-01-13 | 3,683,823 | — | $0 | 3,683,823 | SEC↗ |
| RLYB Rallybio Corp | A Award deriv | 2022-01-03 | 2022-01-05 | 5,772 | — | $0 | 5,772 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2021-11-16 | 2021-11-18 | 91,836 | $15.30 | $1.41M | 1,766,634 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2021-11-16 | 2021-11-18 | 238,870 | $15.30 | $3.65M | 4,595,089 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | C Conversion deriv | 2021-11-02 | 2021-11-05 | 564,217 | — | $0 | 0 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | C Conversion deriv | 2021-11-02 | 2021-11-05 | 254,512 | — | $0 | 0 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | C Conversion deriv | 2021-11-02 | 2021-11-05 | 318,140 | — | $0 | 0 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | C Conversion deriv | 2021-11-02 | 2021-11-05 | 2,371,739 | — | $0 | 0 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | C Conversion deriv | 2021-11-02 | 2021-11-05 | 318,616 | — | $0 | 0 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | C Conversion | 2021-11-02 | 2021-11-05 | 318,616 | — | $0 | 649,771 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | C Conversion | 2021-11-02 | 2021-11-05 | 2,371,739 | — | $0 | 3,021,510 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | C Conversion | 2021-11-02 | 2021-11-05 | 564,217 | — | $0 | 564,217 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | C Conversion | 2021-11-02 | 2021-11-05 | 254,512 | — | $0 | 3,276,022 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | P Buy | 2021-11-02 | 2021-11-05 | 250,000 | $20.00 | $5.00M | 1,132,357 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | C Conversion | 2021-11-02 | 2021-11-05 | 318,140 | — | $0 | 882,357 | SEC↗ |
| CABA Cabaletta Bio, Inc. | S Sale | 2021-11-01 | 2021-11-03 | 36,544 | $13.00 | $475.1K | 333,144 | SEC↗ |
| CABA Cabaletta Bio, Inc. | S Sale | 2021-11-01 | 2021-11-03 | 258,456 | $13.00 | $3.36M | 1,731,119 | SEC↗ |
| (TRDA Entrada Therapeutics, Inc. | A Award deriv | 2021-10-28 | 2021-11-01 | 23,552 | — | $0 | 23,552 | SEC↗ |
| CABA Cabaletta Bio, Inc. | S Sale | 2021-09-07 | 2021-09-09 | 625,000 | $9.70 | $6.06M | 1,989,575 | SEC↗ |
| RLYB Rallybio Corp | P Buy | 2021-08-02 | 2021-08-04 | 615,384 | $13.00 | $8.00M | 1,406,098 | SEC↗ |
| RLYB Rallybio Corp | J Other deriv | 2021-07-28 | 2021-08-04 | 8,742,654 | — | $0 | 0 | SEC↗ |
| RLYB Rallybio Corp | J Other deriv | 2021-07-28 | 2021-08-04 | 1,795,946 | — | $0 | 0 | SEC↗ |
| RLYB Rallybio Corp | J Other deriv | 2021-07-28 | 2021-08-04 | 7,192,795 | — | $0 | 0 | SEC↗ |
| RLYB Rallybio Corp | J Other deriv | 2021-07-28 | 2021-08-04 | 5,034,955 | — | $0 | 0 | SEC↗ |
| RLYB Rallybio Corp | A Award deriv | 2021-07-28 | 2021-08-04 | 13,440 | — | $0 | 13,440 | SEC↗ |
| RLYB Rallybio Corp | J Other | 2021-07-28 | 2021-08-04 | 790,714 | — | $0 | 790,714 | SEC↗ |
| RLYB Rallybio Corp | J Other | 2021-07-28 | 2021-08-04 | 2,784,626 | — | $0 | 2,784,626 | SEC↗ |
| AKUS Akouos, Inc. | A Award deriv | 2021-06-24 | 2021-06-25 | 16,000 | — | $0 | 16,000 | SEC↗ |
| FIXX Homology Medicines, Inc. | A Award deriv | 2021-06-17 | 2021-06-22 | 18,000 | — | $0 | 18,000 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion deriv | 2021-04-27 | 2021-04-29 | 5,876,034 | — | $0 | 0 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion deriv | 2021-04-27 | 2021-04-29 | 13,233,885 | — | $0 | 0 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion deriv | 2021-04-27 | 2021-04-29 | 8,845,942 | — | $0 | 0 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion deriv | 2021-04-27 | 2021-04-29 | 8,201,930 | — | $0 | 0 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion deriv | 2021-04-27 | 2021-04-29 | 1,359,799 | — | $0 | 0 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion | 2021-04-27 | 2021-04-29 | 358,878 | — | $0 | 2,208,334 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | P Buy | 2021-04-27 | 2021-04-29 | 575,000 | $15.00 | $8.63M | 575,000 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion | 2021-04-27 | 2021-04-29 | 101,457 | $13.50 | $1.37M | 2,309,791 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion | 2021-04-27 | 2021-04-29 | 500,932 | — | $0 | 1,849,456 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion | 2021-04-27 | 2021-04-29 | 540,265 | — | $0 | 1,348,524 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion | 2021-04-27 | 2021-04-29 | 808,259 | — | $0 | 808,259 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | J Other deriv | 2021-04-22 | 2021-04-26 | 1,359,799 | — | $0 | 1,359,799 | SEC↗ |
| VOR Vor Biopharma Inc. | C Conversion deriv | 2021-02-09 | 2021-02-09 | 45,000,000 | — | $0 | 0 | SEC↗ |
| VOR Vor Biopharma Inc. | C Conversion deriv | 2021-02-09 | 2021-02-09 | 19,230,768 | — | $0 | 0 | SEC↗ |
| VOR Vor Biopharma Inc. | C Conversion deriv | 2021-02-09 | 2021-02-09 | 19,230,768 | — | $0 | 0 | SEC↗ |
| VOR Vor Biopharma Inc. | C Conversion | 2021-02-09 | 2021-02-09 | 1,414,026 | — | $0 | 4,722,848 | SEC↗ |
| VOR Vor Biopharma Inc. | P Buy | 2021-02-09 | 2021-02-09 | 111,111 | $18.00 | $2.00M | 4,833,959 | SEC↗ |
| VOR Vor Biopharma Inc. | C Conversion | 2021-02-09 | 2021-02-09 | 1,414,026 | — | $0 | 1,414,026 | SEC↗ |
| VOR Vor Biopharma Inc. | P Buy | 2021-02-09 | 2021-02-09 | 444,444 | $18.00 | $8.00M | 1,858,470 | SEC↗ |
| VOR Vor Biopharma Inc. | C Conversion | 2021-02-09 | 2021-02-09 | 3,308,822 | — | $0 | 3,308,822 | SEC↗ |
| VOR Vor Biopharma Inc. | A Award deriv | 2021-02-05 | 2021-02-09 | 16,900 | — | $0 | 16,900 | SEC↗ |
| CABA Cabaletta Bio, Inc. | S Sale | 2021-01-12 | 2021-01-12 | 74,470 | $13.00 | $968.1K | 2,614,575 | SEC↗ |
| CABA Cabaletta Bio, Inc. | S Sale | 2021-01-12 | 2021-01-12 | 10,530 | $13.00 | $136.9K | 369,688 | SEC↗ |
| CABA Cabaletta Bio, Inc. | S Sale | 2021-01-08 | 2021-01-12 | 37,411 | $13.00 | $486.3K | 380,218 | SEC↗ |
| CABA Cabaletta Bio, Inc. | S Sale | 2021-01-08 | 2021-01-12 | 264,589 | $13.00 | $3.44M | 2,689,045 | SEC↗ |
| AKUS Akouos, Inc. | S Sale | 2020-12-29 | 2020-12-31 | 358,352 | $18.00 | $6.45M | 3,153,331 | SEC↗ |
| AKUS Akouos, Inc. | S Sale | 2020-12-29 | 2020-12-31 | 111,648 | $18.00 | $2.01M | 982,453 | SEC↗ |
| FIXX Homology Medicines, Inc. | S Sale | 2020-12-22 | 2020-12-28 | 480,000 | $12.82 | $6.15M | 4,354,484 | SEC↗ |
| FIXX Homology Medicines, Inc. | S Sale | 2020-12-22 | 2020-12-28 | 20,000 | $12.82 | $256.4K | 181,435 | SEC↗ |
| FIXX Homology Medicines, Inc. | S Sale | 2020-12-14 | 2020-12-16 | 328,862 | $11.88 | $3.91M | 4,834,484 | SEC↗ |
| FIXX Homology Medicines, Inc. | S Sale | 2020-12-14 | 2020-12-16 | 6,297 | $13.06 | $82.2K | 215,138 | SEC↗ |
| FIXX Homology Medicines, Inc. | S Sale | 2020-12-14 | 2020-12-16 | 13,703 | $11.88 | $162.8K | 201,435 | SEC↗ |
| FIXX Homology Medicines, Inc. | S Sale | 2020-12-14 | 2020-12-16 | 151,138 | $13.06 | $1.97M | 5,163,346 | SEC↗ |
| CABA Cabaletta Bio, Inc. | S Sale | 2020-12-10 | 2020-12-14 | 36,916 | $14.75 | $544.5K | 417,629 | SEC↗ |
| CABA Cabaletta Bio, Inc. | S Sale | 2020-12-10 | 2020-12-14 | 261,084 | $14.75 | $3.85M | 2,953,634 | SEC↗ |
| FVAM 5:01 Acquisition Corp. | J Other deriv | 2020-11-30 | 2020-12-01 | 235,932 | — | $0 | 1,944,068 | SEC↗ |
| FVAM 5:01 Acquisition Corp. | J Other deriv | 2020-11-17 | 2020-11-18 | 30,000 | — | $0 | 2,180,000 | SEC↗ |
| FVAM 5:01 Acquisition Corp. | J Other | 2020-11-12 | 2020-11-12 | 5,126 | $10.00 | $51.3K | 365,126 | SEC↗ |
| FVAM 5:01 Acquisition Corp. | J Other deriv | 2020-10-16 | 2020-10-20 | 90,000 | — | $0 | 2,210,000 | SEC↗ |
| FVAM 5:01 Acquisition Corp. | J Other | 2020-10-16 | 2020-10-20 | 360,000 | $10.00 | $3.60M | 360,000 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | S Sale | 2020-10-05 | 2020-10-07 | 175,000 | $25.30 | $4.43M | 138,497 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion deriv | 2020-06-30 | 2020-07-02 | 16,858,076 | — | $0 | 0 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion deriv | 2020-06-30 | 2020-07-02 | 10,826,417 | — | $0 | 0 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion deriv | 2020-06-30 | 2020-07-02 | 42,102,730 | — | $0 | 0 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion deriv | 2020-06-30 | 2020-07-02 | 21,072,595 | — | $0 | 0 | SEC↗ |
| AKUS Akouos, Inc. | P Buy | 2020-06-30 | 2020-07-02 | 294,117 | $17.00 | $5.00M | 1,094,101 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion | 2020-06-30 | 2020-07-02 | 799,984 | — | $0 | 799,984 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion | 2020-06-30 | 2020-07-02 | 999,980 | — | $0 | 3,511,683 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion | 2020-06-30 | 2020-07-02 | 1,997,946 | — | $0 | 2,511,703 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion | 2020-06-30 | 2020-07-02 | 513,757 | — | $0 | 513,757 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | S Sale | 2020-06-16 | 2020-06-18 | 19,836 | $33.30 | $660.5K | 313,497 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | S Sale | 2020-06-16 | 2020-06-18 | 4,807 | $33.30 | $160.1K | 75,965 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | S Sale | 2020-06-16 | 2020-06-18 | 115,357 | $33.30 | $3.84M | 1,823,192 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | S Sale | 2020-06-11 | 2020-06-15 | 9,800 | $28.75 | $281.8K | 80,772 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | S Sale | 2020-06-11 | 2020-06-15 | 235,200 | $28.75 | $6.76M | 1,938,549 | SEC↗ |
| FIXX Homology Medicines, Inc. | A Award deriv | 2020-06-10 | 2020-06-12 | 18,000 | — | $0 | 18,000 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | S Sale | 2020-05-19 | 2020-05-21 | 10,200 | $35.15 | $358.5K | 90,572 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | S Sale | 2020-05-19 | 2020-05-21 | 244,800 | $35.15 | $8.60M | 2,173,748 | SEC↗ |
| CABA Cabaletta Bio, Inc. | C Conversion deriv | 2019-10-29 | 2019-10-31 | 1,675,532 | — | $0 | 0 | SEC↗ |
| CABA Cabaletta Bio, Inc. | C Conversion deriv | 2019-10-29 | 2019-10-31 | 3,146,551 | — | $0 | 0 | SEC↗ |
| CABA Cabaletta Bio, Inc. | P Buy | 2019-10-29 | 2019-10-31 | 454,545 | $11.00 | $5.00M | 454,545 | SEC↗ |
| CABA Cabaletta Bio, Inc. | C Conversion | 2019-10-29 | 2019-10-31 | 3,214,721 | — | $0 | 3,214,721 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | C Conversion deriv | 2019-10-07 | 2019-10-09 | 20,519 | — | $0 | 0 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | C Conversion deriv | 2019-10-07 | 2019-10-09 | 492,475 | — | $0 | 0 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | C Conversion deriv | 2019-10-07 | 2019-10-09 | 79,746 | — | $0 | 0 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | C Conversion deriv | 2019-10-07 | 2019-10-09 | 1,913,910 | — | $0 | 0 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | C Conversion | 2019-10-07 | 2019-10-09 | 20,519 | — | $0 | 100,772 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | C Conversion | 2019-10-07 | 2019-10-09 | 492,475 | — | $0 | 2,418,548 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | C Conversion | 2019-10-07 | 2019-10-09 | 79,746 | — | $0 | 80,253 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | C Conversion | 2019-10-07 | 2019-10-09 | 1,913,910 | — | $0 | 1,926,073 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | P Buy | 2019-10-07 | 2019-10-09 | 333,333 | $15.00 | $5.00M | 333,333 | SEC↗ |
| ARVN ARVINAS, INC. | G Gift | 2019-09-24 | 2019-09-26 | 1,700 | — | $0 | 1,775 | SEC↗ |
| ARVN ARVINAS, INC. | J Other | 2019-09-16 | 2019-09-18 | 3,475 | — | $0 | 3,475 | SEC↗ |
| FIXX Homology Medicines, Inc. | A Award deriv | 2019-06-06 | 2019-06-10 | 15,580 | — | $0 | 15,580 | SEC↗ |
| ARVN ARVINAS, INC. | A Award deriv | 2019-05-23 | 2019-05-28 | 12,923 | — | $0 | 12,923 | SEC↗ |
| FIXX Homology Medicines, Inc. | S Sale | 2019-05-16 | 2019-05-20 | 24,600 | $21.47 | $528.2K | 221,435 | SEC↗ |
| FIXX Homology Medicines, Inc. | S Sale | 2019-05-16 | 2019-05-20 | 590,400 | $21.47 | $12.68M | 5,314,484 | SEC↗ |
| FIXX Homology Medicines, Inc. | S Sale | 2018-12-10 | 2018-12-12 | 623 | $26.01 | $16.2K | 246,035 | SEC↗ |
| FIXX Homology Medicines, Inc. | S Sale | 2018-12-10 | 2018-12-12 | 14,952 | $26.01 | $388.9K | 5,904,884 | SEC↗ |
| FIXX Homology Medicines, Inc. | S Sale | 2018-11-23 | 2018-11-27 | 28,495 | $20.04 | $571.0K | 5,919,836 | SEC↗ |
| FIXX Homology Medicines, Inc. | S Sale | 2018-11-23 | 2018-11-27 | 1,187 | $20.04 | $23.8K | 246,658 | SEC↗ |
| FIXX Homology Medicines, Inc. | S Sale | 2018-11-16 | 2018-11-20 | 21,036 | $20.20 | $424.9K | 247,845 | SEC↗ |
| FIXX Homology Medicines, Inc. | S Sale | 2018-11-16 | 2018-11-20 | 504,864 | $20.20 | $10.20M | 5,948,331 | SEC↗ |
| SCPH scPharmaceuticals Inc. | A Award deriv | 2018-06-19 | 2018-06-21 | 6,124 | — | $0 | 6,124 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | A Award deriv | 2018-06-08 | 2018-06-08 | 10,000 | — | $0 | 10,000 | SEC↗ |
| FIXX Homology Medicines, Inc. | C Conversion deriv | 2018-04-02 | 2018-04-04 | 1,187,535 | — | $0 | 0 | SEC↗ |
| FIXX Homology Medicines, Inc. | C Conversion deriv | 2018-04-02 | 2018-04-04 | 4,204,502 | — | $0 | 0 | SEC↗ |
| FIXX Homology Medicines, Inc. | C Conversion | 2018-04-02 | 2018-04-04 | 5,392,037 | — | $0 | 6,722,076 | SEC↗ |
| FIXX Homology Medicines, Inc. | C Conversion | 2018-04-02 | 2018-04-04 | 5,392,037 | — | $0 | 6,722,076 | SEC↗ |
| FIXX Homology Medicines, Inc. | A Award deriv | 2018-03-27 | 2018-03-29 | 31,160 | — | $0 | 31,160 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | A Award deriv | 2017-10-08 | 2017-10-10 | 9,000 | — | $0 | 9,000 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | A Award deriv | 2016-08-24 | 2016-08-25 | 18,000 | — | $0 | 18,000 | SEC↗ |